Summary & Overview
HCPCS A2002: Mirragen Advanced Wound Matrix, Per Square Centimeter
HCPCS Level II code A2002 denotes the Mirragen advanced wound matrix billed per square centimeter as an add-on supply, reported in addition to a primary wound care procedure. Nationally, this code matters because advanced wound matrices represent a growing component of chronic and complex wound management, affecting supply cost, coding practice, and reimbursement for outpatient wound care services.
Key payers covered in this analysis include Aetna, Blue Cross Blue Shield, Cigna Health, UnitedHealthcare, and Medicare. Readers will find a compact review of coding purpose and clinical context, typical sites of use, and an outline of payer coverage considerations. The publication also summarizes available benchmarks and common billing practices, highlights potential policy updates that affect add-on supply reporting, and situates the code within outpatient wound care workflows.
This summary is designed for billing managers, compliance officers, and clinicians involved in wound care who need a concise reference on what A2002 represents, where it is used, and which major payers are relevant to coverage and claim submission. Data not available in the input is noted where applicable in detailed sections.
Billing Code Overview
HCPCS Level II code A2002 describes the Mirragen advanced wound matrix, billed per square centimeter. This entry represents an add-on, list-separately supply used to support wound healing when clinicians apply an advanced wound matrix product during a procedure.
Service type: Advanced wound care supply / biologic matrix
Typical site of service: Outpatient wound care centers, hospital outpatient departments, and clinic-based procedural settings
Clinical & Coding Specifications
Clinical Context
A typical patient is an adult with a chronic, non-healing full‑thickness lower extremity wound (for example, a diabetic foot ulcer or venous stasis ulcer) that has failed conservative wound care (debridement, dressings, offloading, compression) and requires advanced biologic matrix application. The wound care specialist (podiatrist, vascular surgeon, or wound care physician) evaluates the wound in an outpatient wound clinic or ambulatory surgery center. After assessing vascular status, controlling infection, and performing sharp debridement under local anesthesia, the provider measures the wound bed and applies the Mirragen advanced wound matrix product to the prepared wound surface, billed using A2002 per square centimeter as an add-on to the primary debridement or other primary wound procedure. Typical workflow steps include pre-procedure assessment and consent, infection control (topical/systemic as indicated), sharp debridement, hemostasis, application of the matrix to exact wound dimensions, securement with appropriate dressings, patient education on offloading and dressing care, and scheduled follow-up visits for reassessment and possible repeat applications.
Coding Specifications
| Modifier | Description | When to Use |
|---|---|---|
00 | Procedure performed as scheduled (no modifier) | Use when no special circumstances apply and the service is reported normally. |